Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

XERIS PHARMACEUTICALS INC (XERS)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-21Mar-31-21Dec-31-20Sep-30-20Jun-30-20Jun-05-20Mar-31-20Mar-05-20
   10-Q8-K10-K10-Q10-Q8-K10-Q8-K
Revenues   [+]33.326.520.214.75.3 3.3 
            Revenue growth  525.3%696.8%1139.0%31242.6%11234.0% 6978.7% 
Cost of goods sold  11.49.49.36.73.5 1.9 
Gross profit  21.917.110.88.11.8 1.4 
            Gross margin  65.6%64.7%53.7%54.7%33.9% 42.1% 
Selling, general and administrative   [+]79.571.273.776.474.8 72.1 
Research and development  18.418.320.928.239.9 53.9 
Other operating expenses  -0.4-0.3-0.30.50.5 0.5 
EBITDA   [+]-74.1 -82.1-95.6-112.0 -123.9 
            EBITDA margin  -222.5%-267.4%-407.2%-649.0%-2102.2% -3725.1% 
Depreciation and amortization  1.5 1.51.41.4 1.3 
EBIT   [+]-75.6-72.0-83.5-97.0-113.3 -125.2 
            EBIT margin  -227.0%-271.7%-414.4%-658.5%-2127.7% -3763.1% 
Interest expense, net   [+]8.28.47.76.06.8 5.0 
Other income (expense), net   [+]0.20.10.10.40.7 0.7 
Pre-tax income  -83.6-80.4-91.1-102.6-119.4 -129.5 
Income taxes  0.20.10.10.30.3 0.5 
            Tax rate  -0.3%-0.1% -0.3%-0.3% -0.4% 
Net income  -83.8-80.5-91.3-102.9-119.8 -129.9 
            Net margin  -251.5%-303.6%-452.7%-698.8%-2248.3% -3905.8% 
   
Basic EPS   [+]($1.55)($1.71)($2.29)($2.88)($3.87) ($4.61) 
Diluted EPS   [+]($1.55)($1.71)($2.29)($2.88)($3.87) ($4.61) 
   
Shares outstanding (basic)   [+]54.147.039.935.831.0 28.2 
Shares outstanding (diluted)   [+]54.147.039.935.831.0 28.2 
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy